Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Chadwick

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
HIV Medicine|August 30, 2016
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015Anna Maria Geretti, Gary Brook, Claire Cameron, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 8, 2013
Hepatitis E virus infections in HIV-infected patients in Ghana and CameroonTorsten Feldt, Fred Stephen Sarfo, Alexander Zoufaly, et al.
AIDS (London, England)|September 20, 2017
Hepatitis B, hepatitis C, and mortality among HIV-positive individualsAlicia C Thornton, Sophie Jose, Sanjay Bhagani, et al.
Bulletin of the World Health Organization|November 16, 2010
Engaging with the water sector for public health benefits: waterborne pathogens and diseases in developed countriesJonathan W Bridge, David M Oliver, David Chadwick, et al.
Pharmacogenomics|December 19, 2007
The association between polymorphisms in RLIP76 and drug response in epilepsyGuy D Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Plos One|July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver diseaseDaniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
HIV Medicine|August 30, 2016
British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015Anna Maria Geretti, Gary Brook, Claire Cameron, et al.
Plos One|November 13, 2012
Hepatitis B virus infection in HIV-positive individuals in the UK collaborative HIV cohort (UK CHIC) studyHuw Price, Loveleen Bansi, Caroline A Sabin, et al.
AIDS (London, England)|March 4, 2014
Laboratory adverse events and discontinuation of therapy according to CD4(+) cell count at the start of antiretroviral therapySophie Jose, Killian Quinn, Teresa Hill, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|June 8, 2013
Hepatitis E virus infections in HIV-infected patients in Ghana and CameroonTorsten Feldt, Fred Stephen Sarfo, Alexander Zoufaly, et al.
AIDS (London, England)|September 20, 2017
Hepatitis B, hepatitis C, and mortality among HIV-positive individualsAlicia C Thornton, Sophie Jose, Sanjay Bhagani, et al.
Bulletin of the World Health Organization|November 16, 2010
Engaging with the water sector for public health benefits: waterborne pathogens and diseases in developed countriesJonathan W Bridge, David M Oliver, David Chadwick, et al.
Pharmacogenomics|December 19, 2007
The association between polymorphisms in RLIP76 and drug response in epilepsyGuy D Leschziner, Andrea L Jorgensen, Toby Andrew, et al.
The Journal of Infectious Diseases|March 4, 2014
Incomplete reversibility of estimated glomerular filtration rate decline following tenofovir disoproxil fumarate exposureSophie Jose, Lisa Hamzah, Lucy J Campbell, et al.
Plos One|July 14, 2023
Hepmarc: A 96 week randomised controlled feasibility trial of add-on maraviroc in people with HIV and non-alcoholic fatty liver diseaseDaniel Bradshaw, Iga Abramowicz, Stephen Bremner, et al.
Antiviral Therapy|June 20, 2017
The association between detected drug resistance mutations and CD4<sup>+</sup> T-cell decline in HIV-positive individuals maintained on a failing treatment regimenAnna Schultze, Roger Paredes, Caroline Sabin, et al.
Pageof 12